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ABSTRACT
Mass spectrometry has become the tool of choice for most 
investigations in proteomics. Identification of proteins from 
complex mixtures has long been achieved and is now rou-
tinely used in countless high throughput studies. Quantita-
tion by mass spectrometry is comparably newer and many 
different strategies have been proposed. One such strategy 
quantitates the difference in protein expression level among 
samples via extracted ion chromatograms, or spectral counts 
or a combination thereof. Another strategy involves mass 
modifications of the analytes in one or more of the samples 
under investigation. MSMAG has been developed as an 
extension to 2DB and it has been shown that it can aid in 
quantitation of data from experiments employing label-free 
quantitation. Recently, it has been extended to allow for 
analysis of data based on labelling strategies. This also 
makes it possible to quickly visualize and investigate inher-
ent mass differences as presented by post translational modi-
fications. 
1. INTRODUCTION
Proteomics aims to elucidate the protein complement of a 
genome taking into account the spatial and temporal expres-
sion patterns of proteins. Historically one gene was thought 
to produce one protein; today we know that due to alterna-
tive splicing, RNA editing, and protein splicing this is hardly 
the case and one gene usually gives rise to multiple proteins 
with different sequences [1,2]. This creates a large number 
of possible gene products which is further increased by post 
translational modifications (PTMs) in which chemical 
groups are attached to amino acids. Adding PTMs to amino 
acids in the sequence does not lead to a new protein since 
the sequence remains the same but rather creates a new pro-
tein species [3,4]. Systems biology is interested in all protein 
species expressed by a genome, their interactions, expres-
sion patterns, locations, and their absolute and relative quan-
tity under all possible conditions [5]. While the goal seems 
elusive it is important to create the tools necessary to enable 
steps towards the overall aim of systems biology. 
Mass spectrometry (MS) has become the tool of choice 
when studying proteins [6]. Due to the complexity of MS 
data many software tools [7-9] have been proposed for 
analysis and different data storage facilities have been de-
veloped [10-12]. We recently developed 2DB, an application 
for storage, analysis and presentation of results from 
MS/MS analyses which was first introduced at the 2007 
HIBIT and whose improvements have been presented at the 
2009 HIBIT symposium [13]. In addition to protein identifi-
cation, which MS has long been used for, protein quantities 
and their relative differences among samples can now be 
examined. Two general strategies are employed for quantita-
tion. One of these involves differential labelling of peptides 
in different samples with a marker which changes the mass 
such that the mass to charge ratio (m/z) difference between 
labelled and unlabelled analytes can be differentiated by a 
mass spectrometer [14-16]. Labelling implies an additional 
effort which involves extra cost and an increase in labour 
time as well as a potential raise in sample complexity [17] 
whereas label-free quantitation may be done without extra 
effort. Relative protein quantities can be determined without 
the need for adding a label to the analytes based on the no-
tion that protein abundance and number of spectra and in-
tensity of precursor ions are correlated [18-20]. One method 
to perform label-free quantitation with liquid chromatogra-
phy (LC) MS/MS data is to perform spectral counting [21-
23]. In addition to spectral counting, the count can be 
weighted by the total ion current (TIC) [24,25] or the re-
ported score of the identification software [26].  
MSMAG is an extension to 2DB and can be used for label-
free quantitation essentially as a new feature in the analysis 
and presentation module while the underlying data model 
remains unchanged [25]. Since PTMs are also modeled in the 
database, it was natural to extend the quantitation facility and 
allow for quantitation of labeled analytes. Viewing labels as 
an arbitrary change in the measurable mass to charge ratio 
(m/z) opens the possibility to treat inherent PTMs as if they 
were labels. With this notion, MSMAG has been extended to 
allow for visualization of the distribution of PTMs over the 
fractions of a sample. Additionally, the interactive quantita-
tion of labels and PTMs among samples has been enabled 
and thus relative quantities of modified and unmodified ana-
lytes can be investigated. A dataset has been created in silico
to test the new features. This dataset will be presented in the 
next section.  
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2. PRELIMINARIES
MSMAG is a part of a larger system and provides just one 
of several analysis and display possibilities of mass spec-
trometry based proteomics data stored in 2DB.  
2.1 Data Import and MSMAG Analysis Steps 
? First an instance of 2DB needs to be created if none 
is available (see 2DB manual for details).  
o This step involves import of protein se-
quence information for target organisms. 
o Setting confidence thresholds for the 
MS/MS identification software used. 
? Then data from MS/MS experiments can be im-
ported into the database. Different formats such as 
standards like pepXML are supported in this step 
(http://tools.proteomecenter.org/wiki/index.php?title
=Formats:pepXML).
? The data can be amended with location information 
as for example an image of the source gel. 
? In regards to analysis with MSMAG, the identified 
PTMs are automatically extracted from these results 
(mass differences only). 
? PTMs whose mass have not been named in 2DB 
can be given a name using 2DB functions (for read-
ability). 
? After all data has been imported, the significantly 
identified proteins can be investigated using 2DB 
functions.  
? For in-depth analysis MSMAG can be selected 
from the Experiments menu of 2DB. 
? Within MSMAG the first step is to select the ex-
periments in 2DB that shall be analyzed. 
? With that selection it is possible to either perform an 
analysis of the peptide and protein distribution over 
the experiment or investigate the differential pep-
tide/ protein expression among selected experi-
ments. 
? The expression profile displays the proteins, their 
associated peptides, and their associated mass spec-
tra (Figure 1). 
? The quantitation choice (Figure 3) needs several 
settings before data can be displayed. 
? For normalization of data housekeeping proteins 
can be selected from peptides shared among sam-
ples. 
? The PTMs that shall be considered need to be se-
lected from the list of available PTMs. 
? The pooling type can be set (Settings – Pooling 
Type). 
? Also some mathematical calculations can be se-
lected or deselected in the Settings menu. 
? View allows for modifying the output and allows 
for showing raw data instead of calculated ratios for 
instance. 
? The most important setting is under Run - Quantita-
tion Mode. Here the appropriate quantitation 
method needs to be chosen before selecting Run – 
Quantitation.
? The results can be viewed in MSMAG, copied from 
the provided data tables, saved in different formats 
for later offline analysis and exported as images. 
3. MATERIALS AND METHODS 
In a study on simulating spectra from LC-MS data, Schulz-
Trieglaff et al. created large in silico datasets based on 
mouse proteins [27]. When introducing MSMAG the data 
accompanying its introduction were based on that dataset 
since no other, more targeted, experimental dataset was 
freely available. Modifying the dataset to include PTMs was 
achieved by randomly modifying the peptide identifications 
in the dataset in regard to their precursor mass and their 
abundance. Three different modifications were used which 
were named ctLA, ctLB, and ctLC and were set to create a 
shift in precursor mass by 5, 10, and 21 Dalton (Da), respec-
tively. The modifications are assumed to have no influence 
on the chemical properties of the amino acid and shall there-
fore not lead to a shift in the LC elution time. Each identi-
fied peptide was selected in turn and a random number be-
tween 1 and 10 was generated. If the random number was 3 
or less, the peptide was modified by generating another ran-
dom number in-between 1 and 3 to select one of the three 
possible modifications. For each identified peptide the 
abundance was adjusted in case a modification was added. 
The TIC was adjusted between 70 and 160% of its original 
value; again by generating a random number in that range. 
The modification was added to the identification and the 
original identification was removed from the dataset. This 
leads to a serration of data with less identification per un-
modified peptide. With some quantitation methods, it is es-
sential to have both a modified and an unmodified version 
of the peptide within the pool of identifications. With this 
method of generating the data set, this cannot be guaranteed 
and it seems likely that the number of quantifiable identifi-
cations may be rather low. 
The data was imported into an instance of 2DB 
(http://www.biolnk.com/2DB) where it can be accessed pub-
licly. The experiments were entitled A-LUin1 to F-LUin1. 
This dataset shall serve as an example in the following sec-
tions. 
4. RESULTS AND DISCUSSION 
4.1 Protein and Peptide Expression Profiling 
Data that has been imported into 2DB and can be analyzed 
using MSMAG which can be accessed by selecting Experi-
ments - MSMAG.  
Selecting just one Experiment (here equal to one sample) 
allows for analysis of the protein and peptide distribution 
among the fractions of the experiment (Figure 1). In Figure 
1, the occurrence of the protein with the JGI 
(http://genome.jgi-psf.org/Chlre4/Chlre4.home.html) acces-
sion number 137778 in the fractions of the experiment A-
LUin1 is shown in the top pane. Most of the protein can be 
found in fractions 6 through 9. The protein list in the left 
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pane shows the selected protein with the selected peptide 
highlighted. The selected peptide shows a similar distribu-
tion as the protein and is modified by ctLC in fraction 8 
whereas it carries the modification ctLB in fractions 7 and 9. 
Selecting other peptides constituting the protein reveals the 
remaining modifications for the very heterogeneously modi-
fied fraction 8 (not shown). The first peptide carries the 
modification ctLA whereas the second peptide is modified 
by ctLC, but not quantitatively in fraction 8 (not shown). 
This assessment can help in identifying interesting fractions 
that warrant further investigation. While the motivation to 
perform the expression analysis in MSMAG was at least 
three fold (proteolytic control of proteins under different 
experimental conditions, finding samples for pooling, and 
detecting of proteotypic peptides). The program is now even 
more useful with the additional knowledge about the distri-
bution of PTMs and/or labels that it provides. It is now pos-
sible to understand why a protein is found in different frac-
tions since the differential PTMs of the protein in different 
fractions can be considered. 
4.2 Re-establishing Peptide LC-Profiles 
 Although PTMs may change the chemical properties of the 
modified peptides and thus lead to different elution times in 
LC-MS/MS experiments, such modifications merely present 
an additional mass attached to an amino acid for MS anlysis. 
Thus for analyses such as those possible with the combina-
tion of 2DB and MSMAG altered chemical properties have 
no influence since the analyses are based on results from 
spectra identified by one or more database search algo-
rithms. The modified chemical behaviour can, however, be 
investigated using the newly established LC-Profile display 
(Figure 2). In Figure 2 the LC profile has an unexpected 
distribution which is due to the way the data was generated 
and is not to be expected with experimental data. Using the 
LC-Profile view allows for a deeper analysis of the underly-
ing raw data which was not possible with the prior version 
of MSMAG. Depending on the LC separation, peptides with 
modifications could be expected to elute in a certain order 
which can, for example, be verified using the LC-Profile 
display. The relative abundance of the peptide with different 
modifications can be derived from this re-established LC 
profile similar to using the expression profiling view but 
with information about elution time and the measured TIC. 
4.3 Quantitation with Post Translational Modifications 
Since PTMs and labels are modelled in the same way within 
2DB, it is possible for MSMAG to retrieve information from 
Figure 1: Screenshot of MSMAG displaying the protein and peptide distribution of the experiment A-LUin1. Modi-
fied peptides are coloured (see colour code below panes). The protein (137778) shows all possible modifications in 
fraction 8. However the selected peptide is only modified by ctLC in the fraction which means that the other peptides 
supporting the protein must carry the remaining modifications to account for the modifications to the protein in that 
fraction. Selecting them reveals their modifications and thus confirms this assumption. 
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2DB in a structured manner independent of whether a modi-
fying PTM or label is present. This abstracts from the need 
to differentiate among diverse modifying agents. This sim-
plification enables the user to perform quantitation based on 
labels or based on PTMs. Clearly, there must be a way to 
select which modification(s) ought to be used in a quantita-
tion analysis. The new, modification aware, version of 
MSMAG therefore provides a box (Figure 4, bottom left 
corner) that lists all modifications that were mapped to pep-
tides in the experiments that were selected for quantitation. 
From these modifications the ones that should be used in the 
analysis need to be selected (holding down the control key 
and clicking several modifications, allows for multiple se-
lections). For performing label-free analysis no modifica-
tions need to be selected; for performing analyses involving 
labels, however, at least one of the modifications needs to be 
selected.
Once this selection is done, the quantitation method needs to 
be selected which can be chosen from Run – Quantitation 
Mode. Available quantitation modes include the following 
possibilities: 
? Label free comparison 
? Labelled sample versus unlabelled sample 
? Labelled sample versus labelled sample (similar to 
label free comparison) 
? Compare among labels within a sample 
Figure 3 shows the label-free comparison of the samples A-
LUin1 to F-LUin1 which have a slight increasing trend from 
A to F. Label-free comparison was possible in the previous 
version of MSMAG and does not present a new develop-
ment. Improvements are, for example, the comparison of 
labelled versus unlabelled samples and the comparison of 
samples containing both labelled and unlabelled versions of 
the analytes at the same time (Figure 4). In Figure 4 no trend 
from experiment A-LUin1 to F-LUin1 can be seen. The trend 
which was barely visible in the label-free analysis disappears 
when doing the comparison of ctLA labelled and unlabelled 
Figure 2: Re-established LC profile for the selected peptide AGETLSEVLSK. The peptide modified by ctLC (blue) 
elutes at about the same time but has a much lower area under the peak as compared to the unmodified peptide 
(red). With real experimental data, large shifts in elution time are to be expected but have not been included in the 
model for this data set. 
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proteins among experiments. This is to be expected from the 
set-up of the data. Modifications were added randomly to the 
data and thus the abundances of peptides, containing the la-
bel and those that do not, are random. Therefore, the ratio 
they produce is random and finally their ratio among experi-
ments is also random. Another difference that is immediately 
visible is that the number of proteins is significantly reduced. 
This is due to the fact that only proteins that were found in all 
experiments are shown in Figure 4 whereas all proteins that 
were identified were shown in Figure 3. This can be selected 
via checking View – show All Proteins. Another reason why 
the number of proteins that can be assessed is significantly 
fewer is that only those proteins come into the first stage of 
analysis which have peptides carrying the modification ctLA 
and corresponding unlabelled peptides identifications in the 
same sample. In the second stage of analysis when experi-
ments are compared, only those proteins which are present in 
all samples are further analyzed. Therefore, the number of 
proteins is significantly reduced. Allowing several labels will 
increase the number of proteins that can be analyzed but at 
the cost of basing the analysis on a mixture of modified pep-
tides that are compared to unmodified ones which are then 
compared among samples. 
The heat maps seen in Figure 3 and Figure 4 are intended for 
visualization and quick assessment of the data. For a more 
thorough analysis, the data can be exported (File – Export), 
or copied from the table under the Protein Details tab. In ad-
dition to the protein heat map and the protein details table, 
similar information is available for the peptides supporting 
the proteins. A heat map for peptides is found under the tab 
Peptide Overview and Peptide Details contains the numerical 
information for the analysis and for each fraction separately. 
Options such as using peptide standards for normalization are 
not detailed in this work; they have been presented when 
MSMAG was first introduced [25]. 
Figure 3: Label-free comparison of experiments A-LUin1 to F-LUin1 displaying all proteins. This can be regarded
as an overview of the data. The heat map shows a slight trend from colder to warmer colours from the left-most 
sample to the right-most sample which is intentional by design of the data. A-LUin1 is white since it is compared 
with itself and thus should not display any up- or down-regulation. 
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5. CONCLUSION 
A new version of MSMAG has been developed which  
1. amends the expression profiling with information 
about PTMs 
2. allows for new modes of quantitation  
3. can perform quantitation with or without labels or 
PTMs
4. provides a new view of the re-established peptide 
LC profile with or without modifications 
While only label-free quantitation was possible with the pre-
vious version of MSMAG, the new version has no such limi-
tation and models both labels and PTMs as arbitrary mass 
shifts to peptides. Some new modes of quantitation were 
established to allow quantitation using different strategies. It 
is, however, envisioned that most commonly, label-free com-
parisons or a comparisons of labelled versus unlabeled sam-
ple will be used. The program is part of the 2DB distribution 
(http://www.biolnk.com/2db) and therefore free of charge. 
MSMAG’s source code, as well as all other JAVA™ source 
code that is part of 2DB, is currently not distributed along 
with the 2DB package but can be retrieved from the author 
via email.  
6. OUTLOOK
Currently, no quantitative measure is derived from the area 
under the re-established LC profiles but in the future it will 
be integrated into the analysis. 
Some analyses compare the TIC of labelled and unlabelled 
fragment ions within one spectrum [28]. This is currently 
not supported by MSMAG but will be enabled in the near 
future.
Many mathematical and data mining approaches have been 
developed for micro array studies. In essence, the mathe-
matical problem is the same and thus it is aimed that such 
regularization, feature extraction, and clustering techniques 
will be incorporated into the software. 
7. ACKNOWLEDGMENTS
I would like to thank Anne Frary for proof reading the arti-
cle and for making it more intelligible. This work has been 
Figure 4: Comparison of Samples containing both, proteins with the ctLA modification and proteins without. The 
ratios are compared among the experiments A-LUin1 to F-LUin1. No trend can be seen which was expected since 
the modifications were added randomly. 
???
supported by the Izmir Institute of Technology with the BAP 
grant 2009IYTE30. 
REFERENCES
[1] K.S. Nair, A. Jaleel, Y.W. Asmann, K.R. Short, and S. 
Raghavakaimal, “Proteomic research: potential oppor-
tunities for clinical and physiological investigators,” 
American Journal of Physiology. Endocrinology and 
Metabolism,  vol. 286, Jun. 2004, pp. E863-874. 
[2] E.S. Lander, L.M. Linton, B. Birren, C. Nusbaum, 
M.C. Zody, J. Baldwin, K. Devon, K. Dewar, M. 
Doyle, W. FitzHugh, et al. “Initial sequencing and 
analysis of the human genome,” Nature,  vol. 409, 
Feb. 2001, pp. 860-921. 
[3] P. Jungblut, B. Thiede, U. Zimny-Arndt, E.C. Müller, 
C. Scheler, B. Wittmann-Liebold, and A. Otto, “Reso-
lution power of two-dimensional electrophoresis and 
identification of proteins from gels,” Electrophoresis,
vol. 17, May. 1996, pp. 839-847. 
[4] H. Schluter, R. Apweiler, H. Holzhutter, and P. 
Jungblut, “Finding one's way in proteomics: a protein 
species nomenclature,” Chemistry Central Journal,
vol. 3, 2009, p. 11. 
[5] S. Oeljeklaus, H.E. Meyer, and B. Warscheid, “Ad-
vancements in plant proteomics using quantitative 
mass spectrometry,” Journal of Proteomics,  vol. 72, 
Apr. 2009, pp. 545-554. 
[6] R. Aebersold and M. Mann, “Mass spectrometry-based 
proteomics,” Nature,  vol. 422, Mar. 2003, pp. 198-
207.
[7] I. Shadforth, D. Crowther, and C. Bessant, “Protein 
and peptide identification algorithms using MS for use 
in high-throughput, automated pipelines,” Proteomics,
vol. 5, Nov. 2005, pp. 4082-95. 
[8] D.C. Chamrad, G. Korting, K. Stuhler, H.E. Meyer, J. 
Klose, and M. Bluggel, “Evaluation of algorithms for 
protein identification from sequence databases using 
mass spectrometry data,” Proteomics,  vol. 4, Mar. 
2004, pp. 619-28. 
[9] E. Kapp, F. Schutz, L. Connolly, J. Chakel, J. Meza, C. 
Miller, D. Fenyo, J. Eng, J. Adkins, G. Omenn, and R. 
Simpson, “An evaluation, comparison, and accurate 
benchmarking of several publicly available MS/MS 
search algorithms: sensitivity and specificity analysis,” 
Proteomics,  vol. 5, Aug. 2005, pp. 3475-90. 
[10] K. Garwood, T. McLaughlin, C. Garwood, S. Joens, N. 
Morrison, C.F. Taylor, K. Carroll, C. Evans, A.D. 
Whetton, S. Hart, D. Stead, Z. Yin, A.J. Brown, A. 
Hesketh, K. Chater, L. Hansson, M. Mewissen, P. 
Ghazal, J. Howard, K.S. Lilley, S.J. Gaskell, A. Brass, 
S.J. Hubbard, S.G. Oliver, and N.W. Paton, “PEDRo: a 
database for storing, searching and disseminating ex-
perimental proteomics data,” BMC Genomics,  vol. 5, 
Sep. 2004, p. 68. 
[11] J. Hartler, G. Thallinger, G. Stocker, A. Sturn, T. 
Burkard, E. Korner, R. Rader, A. Schmidt, K. Mecht-
ler, and Z. Trajanoski, “MASPECTRAS: a platform 
for management and analysis of proteomics LC-
MS/MS data,” BMC Bioinformatics,  vol. 8, 2007, p. 
197.
[12] P. Pernet, A. Bruneel, B. Baudin, and M. Vaubourdolle, 
“PHProteomicDB: a module for two-dimensional gel 
electrophoresis database creation on personal web 
sites,” Genomics Proteomics Bioinformatics,  vol. 4, 
May. 2006, pp. 134-6. 
[13] J. Allmer, S. Kuhlgert, and M. Hippler, “2DB: a Pro-
teomics database for storage, analysis, presentation, 
and retrieval of information from mass spectrometric 
experiments,” BMC Bioinformatics,  vol. 9, Jul. 2008, 
pp. 302-313. 
[14] S.P. Gygi, B. Rist, S.A. Gerber, F. Turecek, M.H. Gelb, 
and R. Aebersold, “Quantitative analysis of complex 
protein mixtures using isotope-coded affinity tags,” 
Nature Biotechnology,  vol. 17, Oct. 1999, pp. 994-
999.
[15] J. Krijgsveld, R.F. Ketting, T. Mahmoudi, J. Johansen, 
M. Artal-Sanz, C.P. Verrijzer, R.H.A. Plasterk, and 
A.J.R. Heck, “Metabolic labeling of C. elegans and D. 
melanogaster for quantitative proteomics,” Nature Bio-
technology,  vol. 21, Aug. 2003, pp. 927-931. 
[16] F. Wang, M. Ye, J. Dong, R. Tian, L. Hu, G. Han, X. 
Jiang, R. Wu, and H. Zou, “Improvement of perform-
ance in label-free quantitative proteome analysis with 
monolithic electrospray ionization emitter,” J Sep Sci,
vol. 31, Aug. 2008, pp. 2589-97. 
[17] F. Yang, N. Jaitly, H. Jayachandran, Q. Luo, M.E. 
Monroe, X. Du, M.A. Gritsenko, R. Zhang, D.J. 
Anderson, S.O. Purvine, J.N. Adkins, R.J. Moore, 
H.M. Mottaz, S.J. Ding, M.S. Lipton, D.G. Camp, 
H.R. Udseth, R.D. Smith, and S. Rossie, “Applying a 
targeted label-free approach using LC-MS AMT tags 
to evaluate changes in protein phosphorylation follow-
ing phosphatase inhibition,” J Proteome Res,  vol. 6, 
Nov. 2007, pp. 4489-97. 
[18] R.E. Higgs, M.D. Knierman, V. Gelfanova, J.P. Butler, 
and J.E. Hale, “Comprehensive label-free method for 
the relative quantification of proteins from biological 
samples,” Journal of Proteome Research,  vol. 4, Aug. 
2005, pp. 1442-1450. 
[19] J. Silva, R. Denny, C. Dorschel, M. Gorenstein, I. 
Kass, G. Li, T. McKenna, M. Nold, K. Richardson, P. 
Young, and S. Geromanos, “Quantitative proteomic 
analysis by accurate mass retention time pairs,” Anal 
Chem,  vol. 77, Apr. 2005, pp. 2187-200. 
[20] J. Silva, R. Denny, C. Dorschel, M. Gorenstein, G. Li, 
K. Richardson, D. Wall, and S. Geromanos, “Simulta-
neous qualitative and quantitative analysis of the Es-
cherichia coli proteome: a sweet tale,” Mol Cell Pro-
teomics,  vol. 5, Apr. 2006, pp. 589-607. 
[21] M.P. Washburn, D. Wolters, and J.R. Yates, “Large-
scale analysis of the yeast proteome by multidimen-
sional protein identification technology,” Nature Bio-
technology,  vol. 19, Mar. 2001, pp. 242-247. 
[22] H. Liu, R.G. Sadygov, and J.R. Yates, “A model for 
random sampling and estimation of relative protein 
abundance in shotgun proteomics,” Analytical Chemis-
try,  vol. 76, Jul. 2004, pp. 4193-4201. 
???
[23] A. Gilchrist, C.E. Au, J. Hiding, A.W. Bell, J. Fernan-
dez-Rodriguez, S. Lesimple, H. Nagaya, L. Roy, S.J.C. 
Gosline, M. Hallett, J. Paiement, R.E. Kearney, T. 
Nilsson, and J.J.M. Bergeron, “Quantitative pro-
teomics analysis of the secretory pathway,” Cell,  vol. 
127, Dec. 2006, pp. 1265-1281. 
[24] J.M. Asara, H.R. Christofk, L.M. Freimark, and L.C. 
Cantley, “A label-free quantification method by 
MS/MS TIC compared to SILAC and spectral count-
ing in a proteomics screen,” Proteomics,  vol. 8, Mar. 
2008, pp. 994-999. 
[25] J. Allmer, “Label-free quantitation, an extension to 
2DB,” Amino Acids, Jul. 2009. 
[26] N. Allet, N. Barrillat, T. Baussant, C. Boiteau, P. Botti, 
L. Bougueleret, N. Budin, D. Canet, S. Carraud, D. 
Chiappe, N. Christmann, J. Colinge, I. Cusin, N. Daf-
flon, B. Depresle, I. Fasso, P. Frauchiger, H. Gaertner, 
A. Gleizes, E. Gonzalez-Couto, C. Jeandenans, A. 
Karmime, T. Kowall, S. Lagache, E. Mahé, A. Mas-
selot, H. Mattou, M. Moniatte, A. Niknejad, M. 
Paolini, F. Perret, N. Pinaud, F. Ranno, S. Raimondi, S. 
Reffas, P. Regamey, P. Rey, P. Rodriguez-Tomé, K. 
Rose, G. Rossellat, C. Saudrais, C. Schmidt, M. Vil-
lain, and C. Zwahlen, “In vitro and in silico processes 
to identify differentially expressed proteins,” Pro-
teomics,  vol. 4, Aug. 2004, pp. 2333-2351. 
[27] O. Schulz-Trieglaff, N. Pfeifer, C. Gropl, O. Kohl-
bacher, and K. Reinert, “LC-MSsim - a simulation 
software for liquid chromatography mass spectrometry 
data,” BMC Bioinformatics,  vol. 9, 2008, p. 423. 
[28] B. Naumann, A. Busch, J. Allmer, E. Ostendorf, M. 
Zeller, H. Kirchhoff, and M. Hippler, “Comparative 
quantitative proteomics to investigate the remodeling 
of bioenergetic pathways under iron deficiency in 
Chlamydomonas reinhardtii,” Proteomics,  vol. 7, Nov. 
2007, pp. 3964-79. 
